Brief: Integra Lifesciences Q2 Adjusted EPS USD 0.63 Vs. IBES Estimate USD 0.62
29/07/2024 11:00
Jul 29 (Reuters) - Integra Lifesciences Q2 adjusted EBITDA USD 83.8 million vs. IBES estimate USD 80.3 million. * Q2 revenue USD 418.2 million vs. IBES estimate USD 413.2 million * Q2 adjusted net income USD 49 million vs. IBES estimate USD 50.1 million * Q2 adjusted gross margin 65.2% * outlook FY revenue USD 1,609-1,629 million
Recent news on Integra LifeSciences Holdings
See all newsIntegra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary
Integra Lifesciences Q3 revenue slightly misses estimates on flood damage
Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Brief: Integra Announces Completion Of Refinancing Transactions
Brief: Integra Announces Pricing Of Senior Secured Notes